During the past decade, Hopelands Cancer Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopelands Cancer Centre" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hopelands Cancer Centre" are "Breast Cancer" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Castration-Resistant Prostate Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "PD-L1 Negative" (1 trials). Many other conditions were trialed in "Hopelands Cancer Centre" in a lesser frequency.

Most popular intervention types in "Hopelands Cancer Centre" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Gemcitabine" (2 trials), "Placebo" (2 trials) and "Sacituzumab Govitecan-hziy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopelands Cancer Centre" are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hopelands Cancer Centre". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopelands Cancer Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopelands Cancer Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".